ACST - Acasti Pharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
2/28/2016
Total Revenue
0
0
0
-
38
Cost of Revenue
-
-
-
-
81
Gross Profit
-
-
-
-
-44
Operating Expenses
Research Development
37,698
38,366
15,669
-
7,389
Selling General and Administrative
7,043
5,659
4,027
-
2,178
Total Operating Expenses
44,741
44,025
19,696
-
9,568
Operating Income or Loss
-44,741
-44,025
-19,696
-
-9,611
Interest Expense
364
365
1,464
-
2
Total Other Income/Expenses Net
-11,372
-6,998
-344
-
2,201
Income Before Tax
-55,901
-51,566
-21,504
-
-6,317
Income Tax Expense
-
0
-
-
-
Income from Continuing Operations
-55,901
-51,566
-21,504
-
-6,317
Net Income
-55,901
-51,566
-21,504
-
-6,317
Net Income available to common shareholders
-55,901
-51,566
-21,504
-
-6,317
Reported EPS
Basic
-
-0.95
-1.23
0.00
-0.59
Diluted
-
-0.95
-1.23
0.00
-0.59
Weighted average shares outstanding
Basic
-
54,290
17,487
-
10,660
Diluted
-
54,290
17,487
-
10,660
EBITDA
-
-48,374
-17,368
-
-3,920